Skip to content

CorMedix CRMD Current State And Local Tax Expense Benefit

Current State And Local Tax Expense Benefit at other companies

TFX
TeleflexTFX
$1.91M-36.6%
Baxter International logo
Baxter InternationalBAX
$7.25M+38.1%
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:CurrentStateAndLocalTaxExpenseBenefit.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's current state and local tax expense benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's current state and local tax expense benefit?
CorMedix (CRMD) reported current state and local tax expense benefit of $2.51M in Q4 2025.
How has CorMedix's current state and local tax expense benefit changed year-over-year?
CorMedix's current state and local tax expense benefit increased by 819.5% year-over-year, from -$348.75K to $2.51M.
What does current state and local tax expense benefit mean?
The current-period income tax expense or benefit owed to or receivable from state and local jurisdictions. This metric captures the tax burden imposed by regional authorities, which can vary significantly based on the company's operational footprint. It is used to assess the impact of state-level tax policies on the company's net profitability.